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Advanced, lately diagnosed 
primary hyperparathyroidism in 
a patient mistakenly treated for 
multiple bone metastasis. A case 
report and review of the literature
Abstract
We report a case of 66-years-old woman mistakenly diagnosed as a metasases’ dissemination on a basis of mu-
litifocal skeleton lesion showed by 99mTc-MDP scanning, high serum calcium level and a vague breast tumour 
history. Additionally she suffered had humer and femur fractures. Immobilised and diagnosed as a cancer patient, 
she he was referred to palliative care. In hospice for the first time the suspicion of hyperparathyroidism was raised. 
When 99mTc-MIBI SPECT/CT scan revealed a parathyroid adenoma, also considering her biochemical parameters, 
she underwent the surgery. Following this her biochemical parameters normalised. This case illustrates a pitfall, 
which sometimes happens in this rare disease. A review of literature is provided.
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Introduction
The incidence of primary hyperparathyroidism 
(PHP) is 42 per 100,000 of population. In a group of 
women over 60 years of age its incidence is higher 
and reaches 4 per 1000. In about 80% of cas-
es a single parathyroid adenoma is responsible for 
clinical symptoms [1], which are as follows: fatigue, 
musculoskeletal pain, polyuria, nocturia, polydipsia, 
constipation, heartburn, memory loss, and depres-
sion [2]. Late skeletal manifestation of primary, sec-
ondary and tertiary hyperparathyroidism are bone 
focal lesions known as brown tumors [3]. Primary 
hyperparathyroidism may lead to clinical pitfalls. 
PHP diagnosis is based on elevated serum calcium 
level, and parathormone level simultaneously. In-
creased calcium level in daily practice should raise 
suspicion of parathyroid hyperactivity. Unfortunately, 
patients with oncologic anamnesis can mistakenly 
be treated as patients with metastatic bone disease.
Case report
A 66-years-old woman was referred to Nuclear 
Medicine Department to perform MIBI-Tc99m scin-
tigraphy with intention to localize the hyperactive 
parathyroid gland. She was admitted to hospital 
with high level of parathormone and calcium. The 
patient’s medical history has began in 2003 with 
a diagnosis of osteopenia detected in routine den-
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sitometry. It was interpreted as a postmenopausal 
osteoporosis and was treated with calcium administra-
tion. Densitometry repeated in 2008 revealed progres-
sion of osteopenia. Because of joints’ swelling and pain 
she was referred to rheumatologist who discovered ele-
vated calcium level (3,34 mmol/l) and alkaline phospha-
tise FALK (233 U/L normal values — 32–104 U/L). She 
was advised to consult oncologist and gynaecologist. 
One year later she had a fracture of left humeral neck 
during routine daily activities. No laboratory tests were 
conducted in emergency room. She was advised to con-
sult an oncologist. This wrong direction of diagnostic 
process probably resulted from breast tumor resection 
in anamnesis, which in fact turned out to be benign. 
She was mistakenly treated as cancer patient with 
skeletal localization of metastatic disease — brown 
tumours were wrongly classified as bone metastases. 
In 2010 she manifested renal colic episode. JJ-catheter 
in the left ureter was implanted. In December 2010 she 
was referred to bone scintigraphy in our department, 
performed with 99mTc-MDP. It revealed increased 
multiple focal uptake in left clavicle, left tibia, right 
scapula suggesting that it might correspond to multi-
ple metastases, however the diffused skull uptake and 
general impression might suggest the disturbances in 
calcium–phosphate metabolism (Figure 1).
A few months later patient had another fracture 
— of right femoral neck. Because of immobilization 
and classifying the patient as oncologic with multiple 
bone metastases, she was referred to hospice. 
The physician in palliative care unit for the first 
time raised the suspicion of hyperparathyroidism. 
He holistically analyzed the patient’s history con-
sidering all available data, including calcium and 
phosphate levels, densitometries, bone scintigraphy, 
clinical symptoms and repeated calcium and phosphate 
tests, additionally verifying parathormone level. Para-
thormone turned out to be 1238 pg/ml and calcium 
was 12.06 mg/dl, which finally confirmed the diagnosis. 
Ultrasound revealed no focal abnormality correspond-
ing to parathyroid gland. She was then referred to our 
nuclear medicine department to perform dual-phase 
MIBI-Tc99m planar scintigraphy with additional, tomo-
graphic SPECT-CT imaging. Planar imaging was per-
formed 20 minutes and 120 minutes after injection of 
740 MBq of MIBI-Tc99m solution. SPECT-CT study of 
neck and upper thorax was performed 130 minutes af-
ter tracer administration. Planar and SPECT/CT imaging 
was performed using standard double-head SPECT/CT 
gamma camera (Symbia T6, Siemens, Erlangen Ger-
many). CT scan was a low-dose, non-contrast study. 
The scan revealed retention of tracer in delayed phase, 
which was considered to be hyperactive parathyroid 
gland. Tomographic and hybrid SPECT/CT imaging 
allowed to precisely assess the structure and localiza-
tion of the gland: its size was 51 x 27 x 26 mm and it 
was localized between trachea and vertebral column, 
at the level of C6-Th2. 
The SPECT/CT also showed high accumulation of 
MIBI-Tc99 in the brown tumor of left clavicle (Figure 
2). In October 2011 she was operated — the removed 
tumor was parathyroid adenoma. Biochemical pa-
rameters were normalized.
Discussion and review of literature
Our patient’s history is an unfortunate example 
of a long and incorrect diagnostics with the happy 
ending. She was early classified as a cancer patient, 
despite only a benign breast tumor history, which 
considerably delayed the final correct diagnosis. High 
calcium levels were misinterpreted as a consequence 
of bone metastases. Skeletal pain was interpreted 
as a sequelae of metastatic or rheumatologic disease 
and pathological fractures. 
Such stories however happen. There are several re-
ports on brown tumors or osteitis fibrosa cystica mim-
icking bone metastases on 99mTc-MDP or 99mTc-MIBI 
scintigraphy in the literature [4–22]. False positive 
results may also happen at PET scanning [23–25]
It should be remembered that brown tumors may 
also rarely appear in a deep vitamin D deficiency [26].
Brown tumor is a form of osteitis fibrosa cystica 
(OFC), first described by Engel in 1864 and von 
Recklinghausen. When OFC usually presents as osteo-
malacia, brown tumor is its localized form. The pa-
thology involves excessive osteoclast resorption with 
Figure 1. Increased 99mTc-MDP focal uptake in left 
clavicle, left tibia, right scapula suggesting brown 
tumors and raised diffuse uptake in skull typical for 
calcium-phosphate metabolic disturbances
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Figure 2. SPECT-CT with 99mTc-MIBI presenting high 
uptake in primary parathyroid adenoma localized 
retrotracheally and in brown tumor of left clavicle
destruction of cortical bone, proliferation of fibrotic 
tissue and formation of fibrous cysts [27]. Brown 
tumours may be observed in facial bones — par-
ticularly the jaws, also in ribs, pelvis, humerus and 
femur, also in vertebrae. It has nothing common with 
brown adipose tissue, its brow colour originates from 
blood-originating hemosiderin. From the orthopae-
dic point of view, the risk of pathologic fracture is of 
concern when a brown tumour corrupts over 2/3 of 
the long bone cortex, especially in the weight bearing 
area [20, 28]. After the parathyroidectomy usually 
quite rapid regression of brown tumour follows [29, 
30], although the refractory cases may happen [31]. 
The sources of pitfalls in brown tumours diag-
nostics are numerous.
First, brown tumours are today fairly rare, be-
cause the screening improvements in laboratory 
medicine since the advent of multichannel analyser 
enables early diagnosis and treatment of hyperpar-
athyroidism [27, 32, 33]. The widespread of bone 
densitometry enabled wide screening of those pa-
tients and they are referred to surgeon much sooner 
with a lesser degree of hypercalcemia and greater 
recognition of osteoporosis [33]. In rare cases the 
brown tumour may be the first manisfestation of 
hyperparathyroidism [34]. In Europe today this con-
dition became quite rare. Therefore clinicians some-
times simply forget this possibility. 
On histological exam the lesion may mimic a giant 
cell tumour of bone [35], therefore a bone biopsy 
may be quite contributing or even decisive [20, 29, 
30], but not in all cases. 
Radiologically, the multiple osteolytic lesions may 
be indistinguishable from metastases [36]. 
This refers also to CT and MRI scanning [17, 30, 
37]. On the other hand MRI may be important for 
determination of hemorrhage, cystic component and 
indirect estimation of fracture risk in brown tumour 
[18, 38]. MRI scanning can depict the nature of the 
tumour: solid, mixed solid, cystic or purely cystic, dis-
continuity of bone cortex and adjacent soft tissue en-
hancement, fluid levels [39]. It may be important for 
progniosis, but little useful in differential diagnosis.
On 99mTc-MDP scanning false positive diagno-
sis a metastases’ dissemination may be not distin-
guishable from brown tumours as a results of low 
specificity of bone scanning, visualising any focal 
bone lesion, including also several other benign con-
ditions like trauma, infections and metabolic bone 
diseases [7, 11, 13, 14, 16, 21, 40]. Single focus of 
increased radiotracer’s uptake may represent me-
tastasis in about 50% in patient with an established 
cancer diagnosis. Even in multiple foci up to 35% of 
rib lesions and 53% of spine lesions may not be of 
metastatic character [14, 40].
On 99mTc-MIBI scanning radiotracer’s accumula-
tion is visible in some [6, 7, 17, 27], but not all brown 
tumours [8]. The precise mechanism for the increased 
uptake of 99mTc-MIBI in a brown tumour is not fully 
elucidated, but probably it is secondary to increased 
perfusion, metabolism and osteoclastic activity [7, 
27]. Some authors argue that parallel multifocal 
uptake both in99mTc-MDP or 99mTc-MIBI scanning 
may lead to correct multiple brown tumours diag-
nosis [19], it should be remembered however that 
sestamibi uptake may happen in metastases of di-
verse origin [41]. Also 99mTc-MDP scanning may be 
positive at negative 99mTc-MIBI findings, when a lytic 
component is predominant [16]. 
PET scanning may be contributory, but it was re-
ported to produce false positive results, mimicking 
mestastases dissemination as well [42–45]. It may 
detect brown tumour foci with great sensitivity, but 
it lack parameters SUV including for the differential 
diagnosis [20]. Sometimes it can elucidate previously 
false-negative scintigraphic findings [46]. PET also 
can be useful in staging and restaging of parathyroid 
carcinoma bone metastases [47].
Summary
Therefore, facing all the diagnostics prob-
lems mentioned above the most important is clini-
cal approach. Diagnostic imaging is important for 
estimating of diseases extent, but little contribut-
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ing to differential diagnosis. In such cases, as ours, 
it may be even misleading. Brown tumour should 
always be in mind on the clinician’s list of differen-
tial diagnoses when multiple osteolytic lesions are 
encountered [20]. Then, the synthetic analysis of 
clinical, laboratory and radiological data is neces-
sary. Patients with hypercalcaemia and multifocal 
skeletal lesions should not be treated palliative way 
just because a cancer in their past medical history. 
Hyperparathyroidism is curable disease, providing 
the proper diagnosis is established. 
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